Information  X 
Enter a valid email address

Costain Group PLC (COST)

  Print      Mail a friend       Annual reports

Wednesday 15 May, 2019

Costain Group PLC

Dividend - Scrip Alternative

RNS Number : 0137Z
Costain Group PLC
15 May 2019
 

 

COSTAIN GROUP PLC

("Costain")

 

 

2018 Final Dividend - Scrip Alternative

 

Costain announces that, following approval by shareholders at the Company's 2019 Annual General Meeting of the renewal of the scrip dividend scheme, elections have been made by shareholders to receive 197,710 ordinary shares of 50p each in the Company ("Shares") in lieu of cash in respect of all or part of their final dividend for the year ending 31 December 2018, which is to be paid on Friday 17 May 2019.

 

Application has therefore been made for the admission of 197,710 new Shares to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's market for listed securities. The new Shares will rank pari passu with the Company's existing issued Shares and dealings are expected to commence on Friday 17 May 2019.

 

The mandate form and the scrip dividend booklet containing the terms of the Company's scrip dividend scheme are set out on the Company's website at:

http://www.costain.com/investors/shareholder-centre/dividend-scrip/

 

Copies of the above forms have also been submitted to the National Storage Mechanism and are available for inspection at www.morningstar.co.uk/uk/NSM.

 

 

 

 

 

ENQUIRIES:

 

 

15 May 2019

 

Costain Group PLC

  Tel: 01628 842444

Tracey Wood, Company Secretary




 

Instinctif Partners

 

   Tel: 020 7457 2020

Mark Garraway                                                                


James Gray


 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCZZLFFKEFXBBD

a d v e r t i s e m e n t